Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$11.75
-0.41-3.37%
At close: Sep 25, 5:00 PM EST
$11.83
0.080.68%
After Hours: Sep 25, 7:49 PM EST
Intellia Therapeutics Inc (NTLA) Stock Price, Quote, News & History
NTLANASDAQ
Intellia Therapeutics (NTLA) Stock Price, Quote, News & History | Benzinga
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
FAQ
How do I buy Intellia Therapeutics (NTLA) stock?
You can purchase shares of Intellia Therapeutics (NASDAQ:NTLA) through any online brokerage.
Who are Intellia Therapeutics (NTLA) competitors?
Other companies in Intellia Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
What is the forecast, or price target, for Intellia Therapeutics (NTLA) stock?
Intellia Therapeutics has a consensus price target of $25.29.
What is the current price for Intellia Therapeutics (NTLA)?
The stock price for Intellia Therapeutics (NASDAQ: NTLA) is $11.83 last updated September 25, 2026 at 7:49 PM EDT.
Does Intellia Therapeutics (NTLA) pay a dividend?
There are no upcoming dividends for Intellia Therapeutics.
When is Intellia Therapeutics (NASDAQ:NTLA) reporting earnings?
Intellia Therapeutics does not have any upcoming earnings scheduled.
Is Intellia Therapeutics (NTLA) going to split?
There is no upcoming split for Intellia Therapeutics.
What sector and industry does Intellia Therapeutics (NTLA) operate in?
Intellia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
